OSTEOSARCOMA RECURRENT
Clinical trials for OSTEOSARCOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OSTEOSARCOMA RECURRENT trials appear
Sign up with your email to follow new studies for OSTEOSARCOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in fight against returning bone cancer
Disease control OngoingThis study is testing whether two immunotherapy drugs, nivolumab alone or combined with azacitidine, are safe and can help prevent cancer from coming back in patients with recurrent osteosarcoma (a type of bone cancer) that has spread to the lungs but can be surgically removed. P…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo tested in fight against returning bone cancer
Disease control OngoingThis study is testing whether combining two drugs, olaparib and ceralasertib, can help control osteosarcoma (a type of bone cancer) that has come back or stopped responding to standard treatments. It is for patients aged 12 to 40. The main goal is to see if this combination can s…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for tough bone cancers: testing a powerful drug duo
Disease control OngoingThis study is testing whether combining two existing drugs, regorafenib and nivolumab, can better control advanced osteosarcoma (a type of bone cancer) that has come back or stopped responding to standard treatments. It will involve about 48 patients, including children and adult…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC